Transplant-finalized salvage of adult acute lymphoblastic leukemia: Results of a mitoxantrone- and methotrexate-based regimen in 36 patients

Leukemia and Lymphoma

Volumn 46, Issue 6, 2005, Pages 879-884

  Di Bona, Eros ^a,f   Pogliani, Enrico ^c   Rossi, Guiseppe ^d   Lerede, Teresa ^b   D'Emilio, Anna ^a   Vespignani, Michele ^e   Rodeghiero, Francesco ^a   Barbui, Tiziano ^b   Bassan, Renato ^b  

^a Vicenza Hospital   (Italy)

^b Bergamo Hospital   (Italy)

^c Department of Pediatrics   (Italy)

^d Brescia Civic Hospital   (Italy)

^e Venezia Hospital   (Italy)

^f SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Acute lymphoblastic leukemia; Bone marrow transplantation; High dose cytarabine; Salvage therapy

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER MORTALITY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL DISEASE; GRAFT VERSUS HOST REACTION; HEART DISEASE; HUMAN; INFECTION; KIDNEY DISEASE; LIVER DISEASE; LUNG DISEASE; MALE; MEDICAL ASSESSMENT; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REVIEW; SKIN DISEASE; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; MITOXANTRONE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REMISSION INDUCTION; TREATMENT OUTCOME; VINCRISTINE;

EID: 21844457901     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500080801     Document Type: Review

References (24)

1. Welborn JL. Impact of reinduction regimens for relapsed and refractory acute lymphoblastic leukemia in adults. Am J Hematol 1994;45:341-344.
2. Bassan R, Lerede T, Barbui T. Strategies for the treatment of recurrent acute lymphoblastic leukemia in adults. Haematologica 1996;81:20-36.
3. Garcia-Manero G, Thomas DA. Salvage therapy for refractory or relapsed acute lymphocytic leukemia. Hematol Oncol Clin North Am 2001;15:163-205.
4. Martino R, Bellido M, Brunet S, Altes A, Sureda A, Guardia R, Aventin A, Nomdedeu JF, Domingo-Albos A, Sierra J. Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia: results of a prospective trial. Haematologica 1999;84:505-510.
5. Rosen PJ, Rankin C, Head DR, Boldt DH, Luthardt FW, Norwood T, Pugh RP, Karanes C, Appelbaum FR. A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed for refractory adult acute lymphoblastic leukemia. Leuk Res 2000;24:183-187.
6. Kern W, Schleyer E, Braess J, Wittmer E, Ohnesorge J, Unterhalt M, Wormann B, Buchner T, Hiddemann W. Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone (FIS-HAM) salvage therapy in highly resistant acute leukemias. Ann Hematol 2001;80:334-339.
7. Giona F, Annino L, Rondelli R, Arcese W, Meloni G, Testi AM, Moleti ML, Amadori S, Resegotti I, Tabilio A, Ladogana S, Fioritoni G, Camera A, Liso V, Leoni P, Mandelli F. Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R-87 protocol. Br J Haematol 1997;97:896-903.
8. Testi AM, Moled ML, Giona F, Annino L, Chiaretti S, Del Giudice I, Todisco E, D'Elia G, Ferrari A, Arcese W, Mandelli F. A single high dose of idarubicin combined with high-dose ARA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University La Sapienza of Rome. Haematologica 1997;82(5 Suppl):19-22.
9. Weiss MA, Aliff TB, Tallman MS, Frankel SR, Kalaycio ME, Maslak PG, Jurcic JG, Scheinberg DA, Roma TE. A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia. Cancer 2002;95:581-587.
10. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985;103:620-625.
11. Bassan R, Lerede T, Di Bona E, Rambaldi A, Rossi G, Pogliani E, Oriani A, D'Emilio A, Izzi T, Lambertenghi-Deliliers G, Comeo G, Barbui T. Induction-consolidation with an idarubicin-containing regimen, unpurged marrow autograft, and post-graft chemotherapy in adult acute lymphoblastic leukaemia. Br J Haematol 1999;104:755-762.
12. Bassan R, Di Bona E, Rohatiner A, Pogliani E, Rossi G, Porcellini A. Limited success with a postremission strategy comprising conventional consolidation and high-dose treatement (HDT) with autologous peripheral progenitor cell (PBPC) support for adult acute lymphoblastic leukaemia (ALL). Haematol Blood Transfus 2003;41:451-455.
13. Bassan R, Pogliani E, Casula P, Rossi G, Fabris P, Morandi S, Lambertenghi-Deliliers G, Vespignani M, Lerede T, Rambaldi A, Borleri G, Spedini P, Cortelezzi A, Izzi T, Coser P, Broccia G, Corneo G, Barbui T. Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups. Hematol J 2001;2:117-126.
14. Paciucci PA, Cuttner J, Holland JF. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia. Semin Oncol 1984;11(Suppl 1):36-40.
15. Giona F, Annino L, Testi AM, Rondelli R, Arcese W, Meloni G, Moleti ML, Mandelli F. Management of advanced acute lymphoblastic leukemia in children and adults: results of the ALL R-87 protocol. AIEOP and GIMEMA Cooperative Groups. Leuk Lymphoma 1998;32:89-95.
16. Mengarelli A, Iori AP, Cerretti R, Cerilli L, Romano A, Arcese W. Increasing risk of relapse after allogeneic stem cell transplant for adult acute lymphoblastic leukemia in > or = 2nd complete remission induced by highly intensive chemotherapy. Haematologica 2002;87:782-784.
17. Thomas DA, Kantarjian H, Smith TL, Koller C, Cortes J, O'Brien S, Giles FJ, Gajewski J, Pierce S, Keating MJ. Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy. Cancer 1999;86:1216-1230.
18. Ottmann OG, Druker BJ, Sawyers CL, Goldman JM, Reiffers J, Silver RT, Tura S, Fischer T, Deininger MW, Schiffer CA, Baccarani M, Gratwohl A, Hochhaus A, Hoelzer D, Fernandes-Reese S, Gathmann I, Capdeville R, O'Brien SG. A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias. Blood 2002;100:1965-1971.
19. Tafuri A, Gregorj C, Petrucci MT, Ricciardi MR, Mancini M, Cimino G, Mecucci C, Tedeschi A, Fioritoni G, Ferrara F, Di Raimondo F, Gallo E, Liso V, Fabbiano F, Cascavilla N, Pizzolo G, Camera A, Pane F, Lanza F, Cilloni D, Annino L, Vitale A, Vegna ML, Vignetti M, Foa R, Mandelli F; GIMEMA Group. MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. Blood 2002;100:974-981.
20. Boldt DH, Gundacker HM, Lee DY, Yair Gazitt, Forman SJ. Analysis of multidrug resistance gene-1 (MDR1). Expression and function in Adult Acute Lymphoblastic Leukemia (ALL). A Southwest Oncology Group (SWOG) Study. Blood 2002;100(11):756a.
21. List AF, Kopecky KJ, Willman CL, Head DR, Persons DL, Slovak ML, Dorr R, Karanes C, Hynes HE, Doroshow JH, Shurafa M, Appelbaum FR. Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study. Blood 2001;98:3212-3220.
22. Arnold R, Massenkeil G, Bornhauser M, Ehninger G, Beelen DW, Fauser AA, Hegenbart U, Hertenstein B, Ho AD, Knauf W, Kolb HJ, Kolbe K, Sayer HG, Schwerdtfeger R, Wandt H, Hoelzer D. Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease. Leukemia 2002;16:2423-2428.
23. Weisdorf DJ, Billett AL, Hannan P, Ritz J, Sallan SE, Steinbuch M, Ramsay NK. Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia. Blood 1997;90:2962-2968.
24. Rocha V, Labopin M, Ruutu T, Basara N, Jouet JP, Gluckman E, Rigden O, Arcese W, Polge E, Hoelzer D, Frassoni F. Outcomes of HLA identical siblings are comparable to unrelated bone marrow transplants in adults with acute lymphoblastic leukemia. Blood 2002;100(11):77a